Response to Comment-Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published in Lancet Oncology

对 Raje 等人发表于《柳叶刀肿瘤学》杂志上关于接受地诺单抗或唑来膦酸治疗的多发性骨髓瘤患者发生颌骨骨坏死的评论的回应。该评论是对 Raje 等人关键性试验的评述。